Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein

被引:3
|
作者
Tang, Xiao [1 ,2 ,3 ]
Liu, Yang [2 ,3 ]
Wang, Jinhui [2 ,3 ]
Long, Teng [4 ,5 ]
Mok, Bobo Wing Yee [4 ,5 ]
Huang, Yan [2 ,3 ]
Peng, Ziqing [2 ,3 ]
Jia, Qinyu [6 ,7 ]
Liu, Chengxi [6 ,7 ]
So, Pui-Kin [6 ,7 ]
Tse, Sirius Pui-Kam [6 ,7 ]
Liu, Shiyi [8 ]
Sun, Fei [9 ]
Tang, Shaojun [8 ]
Yao, Zhong-Ping [6 ]
Chen, Honglin [4 ,5 ]
Guo, Yusong [2 ,3 ,10 ]
机构
[1] Anhui Normal Univ, Coll Life Sci, Anhui Prov Key Lab Mol Enzymol & Mech Major Metab, Wuhu, Peoples R China
[2] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Peoples R China
[3] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Peoples R China
[4] Univ Hong Kong, Dept Microbiol, Hong Kong, Peoples R China
[5] Univ Hong Kong, Ctr Virol Vaccinol & Therapeut Ltd, Pokfulam, Hong Kong, Peoples R China
[6] Hong Kong Polytech Univ, Res Inst Future Food, Res Ctr Chinese Med Innovat, State Key Lab Chem Biol & Drug Discovery,Kowloon, Hong Kong, Peoples R China
[7] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China
[8] Hong Kong Univ Sci & Technol Guangzhou, Thrust Biosci & Biomed Engn, Guangzhou, Peoples R China
[9] Hong Kong Univ Sci & Technol, Dept Chem & Biol Engn, Hong Kong, Peoples R China
[10] Hong Kong Univ Sci & Technol, Shenzhen Res Inst, Shenzhen, Peoples R China
基金
中国国家自然科学基金;
关键词
ENTRY; ADAM9;
D O I
10.1016/j.jbc.2024.107390
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SARS-CoV-2 entry into host cells is facilitated by the interaction between the receptor-binding domain of its spike protein (CoV2-RBD) and host cell receptor, ACE2, promoting viral membrane fusion. The virus also uses endocytic pathways for entry, but the mediating host factors remain largely unknown. It is also unknown whether mutations in the RBD of SARSCoV-2 variants promote interactions with additional host factors to promote viral entry. Here, we used the GST pull-down approach to identify novel surface-located host factors that bind to CoV2-RBD. One of these factors, SH3BP4, regulates internalization of CoV2-RBD in an ACE2-independent but integrin- and clathrin-dependent manner and mediates SARSCoV-2 pseudovirus entry, suggesting that SH3BP4 promotes viral entry via the endocytic route. Many of the identified factors, including SH3BP4, ADAM9, and TMEM2, show stronger affinity to CoV2-RBD than to RBD of the less infective SARS-CoV, suggesting SARS-CoV-2-specific utilization. We also found factors preferentially binding to the RBD of the SARS-CoV-2 Delta variant, potentially enhancing its entry. These data identify the repertoire of host cell surface factors that function in the events leading to the entry of SARS-CoV-2.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain
    Yang, Mei
    Li, Jiaqi
    Huang, Zhaoxia
    Li, Heng
    Wang, Yueming
    Wang, Xiaoli
    Kang, Sisi
    Huang, Xing
    Wu, Changwen
    Liu, Tong
    Jia, Zhenxing
    Liang, Junlang
    Yuan, Xiaohui
    He, Suhua
    Chen, Xiaoxue
    Zhou, Zhechong
    Chen, Qiuyue
    Liu, Siqi
    Li, Jing
    Zheng, Huiwen
    Liu, Xi
    Li, Kenan
    Yao, Xiaojun
    Lang, Bin
    Liu, Longding
    Liao, Hua-Xin
    Chen, Shoudeng
    MICROBIOLOGY SPECTRUM, 2021, 9 (02):
  • [32] Refining the N-Termini of the SARS-CoV-2 Spike Protein and Its Discrete Receptor-Binding Domain
    D'Ippolito, Robert A.
    Drew, Matthew R.
    Mehalko, Jennifer
    Snead, Kelly
    Wall, Vanessa
    Putman, Zoe
    Esposito, Dominic
    DeHart, Caroline J.
    JOURNAL OF PROTEOME RESEARCH, 2021, 20 (09) : 4427 - 4434
  • [33] Global Prevalence of Adaptive and Prolonged Infections' Mutations in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
    Lennerstrand, Johan
    Palanisamy, Navaneethan
    VIRUSES-BASEL, 2021, 13 (10):
  • [34] Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2
    Sakib, Md Minhas Hossain
    Nishat, Aktiya Anjum
    Islam, Mohammad Tarequl
    Raihan Uddin, Mohammad Abu
    Iqbal, Md Shahriar
    Bin Hossen, Farhan Fuad
    Ahmed, Mohammad Imran
    Bashir, Md Samiul
    Hossain, Takbir
    Tohura, Umma Sumia
    Saif, Saiful Islam
    Jui, Nabilah Rahman
    Alam, Mosharaf
    Islam, Md Aminul
    Hasan, Md Mehadi
    Sufian, Md Abu
    Ali, Md Ackas
    Islam, Rajib
    Hossain, Mohammed Akhter
    Halim, Mohammad A.
    Computers in Biology and Medicine, 2021, 136
  • [35] Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2
    Sakib, Md Minhas Hossain
    Nishat, Aktiya Anjum
    Islam, Mohammad Tarequl
    Uddin, Mohammad Abu Raihan
    Iqbal, Md Shahriar
    Bin Hossen, Farhan Fuad
    Ahmed, Mohammad Imran
    Bashir, Md Samiul
    Hossain, Takbir
    Tohura, Umma Sumia
    Saif, Saiful Islam
    Jui, Nabilah Rahman
    Alam, Mosharaf
    Islam, Md Aminul
    Hasan, Md Mehadi
    Abu Sufian, Md
    Ali, Md Ackas
    Islam, Rajib
    Hossain, Mohammed Akhter
    Halim, Mohammad A.
    COMPUTERS IN BIOLOGY AND MEDICINE, 2021, 136
  • [36] A potent neutralizing nanobody targeting a unique epitope on the receptor-binding domain of SARS-CoV-2 spike protein
    Zhang, Yuting
    Wang, Dan
    Xiang, Qi
    Hu, Xiaohui
    Zhang, Yuting
    Wu, Lijie
    Zhang, Zhaoyong
    Wang, Yanqun
    Zhao, Jincun
    McCormick, Peter J.
    Fu, Jinheng
    Fu, Yang
    Zhang, Jin
    Jiang, Haihai
    Li, Jian
    VIROLOGY, 2024, 589
  • [37] Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein
    Behloul, Nouredine
    Baha, Sarra
    Shi, Ruihua
    Meng, Jihong
    VIRUS RESEARCH, 2020, 286
  • [38] Designing of peptide aptamer targeting the receptor-binding domain of spike protein of SARS-CoV-2: an in silico study
    Devi, Arpita
    Chaitanya, Nyshadham S. N.
    MOLECULAR DIVERSITY, 2022, 26 (01) : 157 - 169
  • [39] An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor
    Olanrewaju Ayodeji Durojaye
    Divine Mensah Sedzro
    Talifhani Mushiana
    Henrietta Onyinye Uzoeto
    Samuel Cosmas
    Judith Nnedimkpa Ajima
    Glory Omini Ibiang
    Egyptian Journal of Medical Human Genetics, 21
  • [40] An in silico LLPS perturbation approach in the design of a novel SARS-CoV-2 spike receptor-binding domain inhibitor
    Durojaye, Olanrewaju Ayodeji
    Sedzro, Divine Mensah
    Mushiana, Talifhani
    Uzoeto, Henrietta Onyinye
    Cosmas, Samuel
    Ajima, Judith Nnedimkpa
    Ibiang, Glory Omini
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2020, 21 (01)